Suboxone, the DEA and Opioid REMS
In June I told you about the FDA developing “Risk Evaluation and Mitigation Strategies” (REMS) to put tighter controls on the use of opioid medications. (See URGENT: FDA May Remove or Limit Access to Opioid Pain Medications) One of the strategies being considered is requiring doctors to have special education and... Read more
